DNTH vs RL · rev $6.2M vs P/E 24, rev $8.11B
Dianthus Therapeutics Inc. (DNTH) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
DNTH currently screens at market cap $4.40B. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the DNTH and RL stock pages for the full models.
Not investment advice.